✦ LIBER ✦
Phase 2a Randomized Controlled Trial of Short-Term Activity, Safety, and Pharmacokinetics of a Novel Nonnucleoside Reverse Transcriptase Inhibitor, RDEA806, in HIV-1-Positive, Antiretroviral-Naive Subjects
✍ Scribed by Moyle, G.; Boffito, M.; Stoehr, A.; Rieger, A.; Shen, Z.; Manhard, K.; Sheedy, B.; Hingorani, V.; Raney, A.; Nguyen, M.; Nguyen, T.; Ong, V.; Yeh, L.-T.; Quart, B.
- Book ID
- 127387295
- Publisher
- American Society for Microbiology
- Year
- 2010
- Tongue
- English
- Weight
- 618 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0066-4804
No coin nor oath required. For personal study only.